EZR and depressive symptom measurement: In parallel with preventing the development of depression-like behaviours, treatment with fluoxetine and exposure to EA averted CUMS-induced astrocytic atrophy (Fig. 6) and CUMS-induced decrease of astrocyte-associated ezrin (Fig. 7).